000 01631nam a22003137a 4500
005 20261118125048.0
008 261118s2008 |||||||| |||| 00| 0 eng d
020 _a9781420044355
040 _cPK-LaUMT
082 _a615.6
_bMOD-
245 0 0 _aModified-release drug delivery technology /
_cedited by Michael J. Rathbone . . . [et al.]
250 _a2nd ed.
260 _aNew York :
_bInforma Healthcare,
_c2008
300 _a2 vols
490 _aDrugs and the pharmaceutical sciences ;
_vV.183
500 _aIncludes bibliographical references and index.
520 _aThis two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM
546 _aEng
650 _aControlled release preparations
_917494
650 _aControlled release technology
_917495
650 _aDrug Delivery Systems
_98913
650 _aPharmaceutical technology
_917496
650 _aTechnology, Pharmaceutical
_917497
700 1 _aRathbone, Michael J.
_917498
700 1 _aHadgraft, Jonathan
_917499
700 1 _aRoberts, Michael S.
_917500
700 1 _aLane, Majella E.
_917501
942 _cBK
999 _c144069
_d144069